BAC
Bank of America Corporation
BAC has the edge over BRO overall, supported by stronger fundamentals and stronger modeled upside.
BRO
Brown & Brown, Inc.
BRO trails on the overall score without a compensating advantage in the available component scores.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
BRO Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| N/A | |
| N/A |
BRO's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BRO.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC's PE is in its fair range at 12x. If earnings grow as analysts expect, today's price would be 10x next year's earnings, in its cheap range.
BRO PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 15x | $70.55 | — |
| Current | 23x | $70.55 | — |
| Cheap | 24x | $75.13 | +6.5% |
| Fair | 28x | $86.99 | +23% |
| Expensive | 30x | $94.46 | +34% |
Historical ranges are pointers, not guarantees.
BRO has the edge over BAC in the historical PE scenario, which offers more potential upside but is not a forecast.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
BAC has the edge over BRO on the outlook, with more favorable earnings and revenue expectations.
BRO Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Stable | |
| Stable | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect BRO's profitability to improve, with its earnings and revenue holding steady.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC has the edge over BRO on earnings, with more consistent year-over-year improvement.
BRO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.65 | +49% |
| Q3 2026 | $3.12 | -6.6% |
| Q2 2026 | $3.13 | -9.8% |
| Q1 2026 | $3.07 | -14% |
| Q4 2025 | $3.16 | -8.7% |
| Q3 2025 | $3.34 | -8.7% |
| Q2 2025 | $3.47 | 0% |
| Q1 2025 | $3.59 | +11% |
| Q4 2024 | $3.46 | +13% |
BRO earned $3.12 per share over the past year, down 6.6% from the year before. Its recent earnings include one-off gains.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC's revenue has grown year over year for 10 quarters in a row: $30B last quarter, up 6.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC has the edge over BRO on profitability, with a higher operating margin.
BRO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.7B | +7.4% |
| Q2 2026 | $1.7B | +30% |
| Q1 2026 | $1.9B | +35% |
| Q4 2025 | $1.6B | +36% |
| Q3 2025 | $1.6B | +35% |
| Q2 2025 | $1.3B | +9.1% |
| Q1 2025 | $1.4B | +12% |
| Q4 2024 | $1.2B | +15% |
BRO has the edge over BAC on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 19% | -0.8 points |
| Q2 2026 | 23% | -1.3 points |
| Q1 2026 | 28% | -2.4 points |
| Q4 2025 | 20% | -3.3 points |
| Q3 2025 | 19% | -7.4 points |
| Q2 2025 | 24% | -5.2 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 23% | -11 points |
BRO's operating margin was 19% last quarter, down 0.8 points from the same quarter a year ago, near the bottom of its range since 2019.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC's free cash flow was $41.4B over the past year, down 33% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BAC.
BRO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $493M | +9.1% |
| Q2 2026 | $329M | +6.1% |
| Q1 2026 | $241M | +23% |
| Q4 2025 | $424M | +24% |
| Q3 2025 | $452M | +8.4% |
| Q2 2025 | $310M | -7.2% |
| Q1 2025 | $196M | +$196M |
| Q4 2024 | $341M | +24% |
BRO has the edge over BAC on cash flow, with more consistent year-over-year improvement.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over BRO on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
BRO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.2% | -4M shares |
| 1 year | -0.6% | -2M shares |
| 3 years | +17% | +48.7M shares |
| 5 years | +19% | +53.1M shares |
| Available history | +20% | +55.4M shares |
BRO has 330M diluted shares, down 0.6% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $250M |
| Q2 2026 | $250M |
| Q1 2026 | $250M |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | $100,000 |
| Q4 2022 | — |
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
BRO Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 4.1x | High |
| Q2 2026 | 4.2x | High |
| Q1 2026 | 4.4x | High |
| Q4 2025 | 4.6x | High |
| Q3 2025 | 4.8x | High |
| Q2 2025 | -1.0x | Net Cash |
| Q1 2025 | 2.2x | Moderate |
| Q4 2024 | 2.3x | Moderate |
BRO has the edge over BAC on leverage, with a lower net debt burden relative to earnings.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
BRO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 53.2 | Neutral |
| Stochastic | 69.7 | Neutral |
BRO's weekly RSI is 53 (neutral) and its Stochastic is 70 (neutral).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC has the edge over BRO on valuation relative to its sector.
BRO PE vs Financial Services Sector
| Metric | BRO | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 13x | 74% above |
| PE % | 9 | 63 | 54 pts below |
BRO is trading at 23x earnings, a 74% premium to the Financial Services sector's median of 13x, though its earnings don't support one.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
BRO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $67.3 | 4.8% above |
| 20 week MA | $68.7 | 2.7% above |
| 50 week MA | $68.6 | 2.8% above |
| 100 week MA | $85.8 | 18% below |
| 200 week MA | $82.8 | 15% below |
BRO has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has the edge over BRO on returns for 2026, with the stronger performance.
BRO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $39.3 | $46.3 | +18% |
| 2021 | $46.3 | $68.0 | +47% |
| 2022 | $68.0 | $56.9 | -16% |
| 2023 | $56.9 | $71.1 | +25% |
| 2024 | $71.1 | $102.9 | +45% |
| 2025 | $102.9 | $80.8 | -21% |
| 2026 YTD | $80.8 | $70.6 | -13% |
BRO has finished higher in four of the last six years. It's down 13% so far in 2026.